According to court documents, in 2018, Dr. O’Rourke entered an illegal agreement with a company where the company completed physicians’ orders for Medicare via an internet-based platform. Dr. O’Rourke would then access the platform and sign the orders in exchange for a payment of $25 per patient without ever interacting with the patients.
In May 2019, for example, Dr. O’Rourke received $5,500 for electronically signing and ordering cancer genomic tests and durable medical equipment.
The Medicare program paid approximately $2,702,150 to Medicare providers for the tests and equipment ordered by Dr. O’Rourke.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.